An Effective Peptide Vaccine Against the Zika Virus
ISEF · 2018 Microbiology Fourth Award
Overview
No effective vaccine against Zika, a positive, single-stranded RNA virus, has been developed. A major obstacle in the design of an antiviral peptide vaccine is the cross-reactivity between the Zika virus and the Dengue virus as both belong to the same family of Flaviviridae, and the Zika virus is emerging in areas where the Dengue virus is endemic. As a result of cross-reactivity between the two viruses, the accentuated immune response may be fatal. While previous studies have focused on the structural proteins of the virus, this study examines various short amino acid sequences of the nonstructural protein 3, NS3, (617 aa) for immunological competence to be CD8+ T cell epitopes. Using the Immune Epitope Database and Analysis Resource (IEDB), Net CTL Version 1.2, and VaxiJen, one novel CD8+ T cell epitope in the protease region of NS3 that is immunogenic, shows only 33 percent similarity with Dengue virus, has a large population coverage in areas affected by Zika, and is conserved in isolates of Zika from ten geographical regions is identified. In addition, through the tool PrediVac, I determined some potential CD4+ T cell epitopes based on MHC class II binding in 6 geographical regions. To know the validity of these procedures, as a control, the protein sequence of hemagglutinin of human Influenza virus A is put through the same analysis, and the results matched with the well-documented epitopes in the IEDB database. Furthermore, as the synthesis of a peptide vaccine can be difficult, I wrote a program in Python to evaluate a set of epitope sequences for the presence of any challenging amino acids that are not ideal for a peptide vaccine. This cost-effective vaccine can significantly improve the treatment of the Zika virus.
Awards (2)
- Fourth Award of $500 $500
- U.S. Agency for International Development: USAID Science for Development Second Place Award of $3,000. $3,000
Competition history
- ISEF 2018
Resources
Related projects
ISEF · 2019
Controlling the Chikungunya Virus Disease in Dengue Endemic Areas through the Development of a Peptide Vaccine
ISEF · 2017
Exosomes as Vaccine Candidates for Flavivirus Including Zika Virus
ISEF · 2019
The Development of Zika Virus Pseudoparticles: A Novel Model for the Future
ISEF · 2025
Pentavax: Pentraxin Proteins With Dengue Virus Immunoreactivity
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair